Developing an Intervention to Address Suicide Risk During Substance Use Disorder
NCT ID: NCT01127932
Last Updated: 2015-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2010-04-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders
NCT02439762
Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers
NCT02932241
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
NCT04768920
Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge
NCT04168645
Implementation of TBI-RECOVER in Substance Use Treatment
NCT07215221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBT for suicide
CBT for suicide in Substance abuse
The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.
Enhanced care control group
This group is designed to be an active control which provides detailed information about substance use, suicide risk, and depression without providing any CBT or other specific therapy.
Psychoeducation for substance abuse
This active control provides detailed information about substance use, suicide risk, and depression to those enrolled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychoeducation for substance abuse
This active control provides detailed information about substance use, suicide risk, and depression to those enrolled.
CBT for suicide in Substance abuse
The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Report a past lifetime suicide attempt
* Report current suicidal ideation
* Resided in treatment for less than 4 weeks
* In treatment for less than 6 months
Exclusion Criteria
* Diagnosis of schizophrenia or currently psychotic
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark A. Ilgen
Associate Professor of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Community Programs, INC.
Waterford, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.